Listen to the latest hemonc news from international experts
Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances
This is a very exciting time for multiple myeloma (MM) research, with advances in a range of areas from new endpoints, to novel therapies and imaging. In this video, an overview of these updates are given by Gareth Morgan, MD, FRCP, FRCPath, PhD of UAMS Myeloma Institute, Little Rock, AR, Nina Shah, MD of UCSF Medical Center, San Francisco, CA and Leif Bergsagel, MD from the Mayo Clinic, Scottsdale, AZ following day 2 of the Myeloma 2017 meeting in Edinburgh, UK.
Date: 16th November 2017